University Hospitals Birmingham NHS Foundation Trust

Chapters

Status Drug name NICE TAs Comments
Status: Green Atropine injection
Status: Green Domperidone suppositories

Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.

Status: Green Domperidone suspension

Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.

Status: Green Domperidone tablets

Second line - domperidone should not be used by people who have serious underlying heart conditions. It should only be used in the relief of symptoms of nausea and vomiting and at the lowest effective dose for the shortest possible duration. Adults should take no more than three 10mg tablets per day. Domperidone should no longer be used to treat other conditions such as heartburn, bloating or relief of stomach discomfort.

Status: Green Hyoscine butylbromide injection
Status: Green Hyoscine butylbromide tablets
Status: Green Mebeverine tablets 135mg
Status: Green Metoclopramide injections

Not recommended for patients aged 20 years and below due to risk of dystonic reactions.

MHRA guidance - metroclopramide: risk of neurological adverse effects

Status: Green Metoclopramide suspension

Not recommended for patients aged 20 years and below due to risk of dystonic reactions.

MHRA guidance - metroclopramide: risk of neurological adverse effects

Status: Green Metoclopramide tablets

Not recommended for patients aged 20 years and below due to risk of dystonic reactions.

MHRA guidance - metroclopramide: risk of neurological adverse effects

Status: Green Peppermint oil capsules (Mintec)
Status: Red Peppermint water

Unlicensed

Status: Amber Propantheline

Specialist recommendation for hyperhidrosis

Building healthier lives
Back to top